These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1885122)

  • 1. [Pathophysiologic regulatory mechanisms in chronic schizophrenia].
    Klempel K
    Fortschr Neurol Psychiatr; 1991 Jun; 59(6):239-46. PubMed ID: 1885122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiologic aspects of schizophrenic psychoses--a review].
    Schellenberg R; Zwiener U; Kühne GE
    Psychiatr Neurol Med Psychol (Leipz); 1989 Apr; 41(4):193-9. PubMed ID: 2662232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Negative schizophrenic symptomatology and the P 300 potential].
    Drouet A; Hort-Legrand C; Féline A; Métral S
    Encephale; 1993; 19(3):229-35. PubMed ID: 8275908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The P 300 potential in schizophrenia].
    Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PINV--topography and primary negative symptoms in chronic schizophrenia.
    Eikmeier G; Lodemann E
    Pharmacopsychiatry; 1994 Mar; 27(2):63-4. PubMed ID: 8029313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Follow-up dynamics of schizophrenic diseases in adolescence].
    Schulz E; Martin M; Remschmidt H
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):262-74. PubMed ID: 7856322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
    Bralet MC; Yon V; Loas G; Noisette C
    Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular irregularities in schizophrenia--more than an epiphenomenon?].
    Volz HP; Mackert A
    Nervenarzt; 1991 May; 62(5):298-302. PubMed ID: 1865961
    [No Abstract]   [Full Text] [Related]  

  • 10. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The biological correlates of anxiety in psychiatric diseases].
    Albus M
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 67():1-117. PubMed ID: 1775149
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individuals with schizophrenia present hypo- and hyperactivation during implicit cueing in an inhibitory task.
    Arce E; Leland DS; Miller DA; Simmons AN; Winternheimer KC; Paulus MP
    Neuroimage; 2006 Aug; 32(2):704-13. PubMed ID: 16766210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of standardized psychometric scales (BPRS, HDS)in the evaluation of schizophrenic symptoms (preliminary report)].
    Linka M; Rybakowski J
    Psychiatr Pol; 1990; 24(1):15-22. PubMed ID: 2284354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central dopaminergic receptors and negative symptoms in schizophrenia].
    Martinot JL; Paillere-Martinot ML; Loc'h C; Aubin F; Dao-Castellana MH; Deslauriers AG; Syrota A; Lecrubier Y
    Ann Med Psychol (Paris); 1992; 150(2-3):127-30. PubMed ID: 1343506
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology and treatment of negative symptoms.
    Villeneuve A
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
    Ban TA; Ananth JV; Lehmann HE
    Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal synaptic plasticity as a biological substrate underlying episodic psychosis.
    Port RL; Seybold KS
    Biol Psychiatry; 1995 Mar; 37(5):318-24. PubMed ID: 7748983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.